Allergies
-
The results of a clinical trial find introducing gluten into a baby's diet from the age of four months may reduce their risk of developing celiac disease. The researchers stress larger trials are necessary before any broad dietary recommendations are suggested.
-
There may be new hope for people prone to allergic reactions of the skin. According to a new study, one serving of black raspberries per day could minimize the effects.
-
Promising research is reporting progress in the development of an anaphylaxis-preventing pill. The drug, initially designed as an alternative to chemotherapy for some types of cancer, could be taken before meals to prevent serious allergic reactions.
-
Although no one likes getting blood samples drawn or having their skin pricked, these are the most common methods of testing for allergies. Thanks to a new study, however, such uncomfortable pokes could soon be replaced with painless nasal swabs.
-
Scientists investigating the biological processes behind allergic itching have uncovered a protein in the skin they say acts as a switch, offering a potential new target in the ongoing search for more effective treatments.
-
A newly published longitudinal study out of Canada has found a strong association between frequent use of household cleaning products and an increased risk of children developing asthma in the first three years of life.
-
Asthma and other allergic reactions are increasingly common today, and while manageable there’s currently no cure. Now, researchers at Yale University have found a new potential pathway for treatment, targeting cellular "gatekeepers" called microRNA.
-
A comprehensive study from the UK has found that introducing children to certain foods at an early age is associated with a lower risk of developing allergies – and the correlation is clear even when subjects didn’t stick strictly to the regime.
-
Another promising potential treatment for peanut allergies has just emerged via a promising early trial at Stanford University, where scientists found an antibody treatment enabled those with severe allergies to stomach peanuts for some time.
-
First results have been revealed from phase 2 human trials into a promising new treatment for celiac disease. The nanoparticle technology was found to significantly induce an immune tolerance to gluten in celiac subjects after just two treatments.
-
The first oral immunotherapy agent to treat peanut allergy is set to be approved, but questions still remain over how effective and long-lasting it is.
-
Chromium and nickel nanoparticles from tattoo needles may be responsible for some allergic reactions to tattoos.
Load More